KRAS driven expression signature has prognostic power...

European Journal of Cancer 2017 / 02 Vol. 72

KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer

Nagy, A., Pongor, L., Santarpia, M., Gyorffy, B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
72
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(17)30657-3
Date:
February, 2017
File:
PDF, 52 KB
english, 2017
Conversion to is in progress
Conversion to is failed